Drug Type Small molecule drug |
Synonyms KN 510, KN510 |
Target |
Action blockers |
Mechanism SLC25A20 blockers(solute carrier family 25 member 20 blockers) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 11 Sep 2023 | |
Pancreatic Cancer | Preclinical | South Korea | 28 Apr 2025 |